Rituximab in pemphigus.
Amrinder J
AJ
Kanwar
Keshavamurthy
K
Vinay
D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D010392:Pemphigus / Q000188:drug therapy*; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab